ArticleExperimental hematology & oncology2025

A cohort-based multi-omics identifies nuclear translocation of eIF5B /PD-L1/CD44 complex as the target to overcome Osimertinib resistance of ARID1A-deficient lung adenocarcinoma.

Dantong Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.